Partnership

Partner with us

Unimedic Pharma has extensive experience of mutual and strategic partnerships, such as in- and out-licensing. Feel free to contact us for further discussions!

Unimedic Logotype
Unimedic Logotype
Unimedic Logotype
Unimedic Logotype
Unimedic Logotype
Unimedic Logotype
Unimedic Logotype
Ethypharm
Unimedic Logotype

Partnership

Collaboration opportunities

Long-term strategic partnerships and acquisitions are a fundamental part of our business. To continually introduce and launch new pharmaceuticals support our mission to contribute to better health. We have long experience of managing various strategic partnerships and are actively seeking new partners in areas such as in-licensing, out-licensing and acquisitions.

In-licensing

Unimedic Pharma has broad experience from mutually beneficial partnerships and acting on behalf of other pharmaceutical companies as MAH or local representative in the Nordic region. Today, Unimedic Pharma is designated representative for a broad portfolio in emergency care, infectious diseases, and substance abuse. We cover all relevant areas to successfully register, launch, grow or maintain sales. We cover all Nordic markets with a local field-based KAM organisation, supported by personnel in marketing, market access, supply, quality assurance, pharmacovigilance, and regulatory affairs.

Unimedic Pharma subsequently handle products which are already licenced, or products requiring regulatory approval. We understand the importance of being communicative, accessible, and flexible, and sharing mutual and measurable results with our partners. For us, this is fundamental in a successful partnership.

Out-licensing

Unimedic Pharma has a proprietary drug portfolio in pain, CNS, urology, and gastroenterology. We supply the portfolio of drugs across the Nordic countries, and through partners in selected markets in northern Europe. Please contact us if you are interested in discussing partnership with regards to Unimedic Pharma product portfolio and launching the pharmaceuticals on new markets in Europe.

Acquisitions

MedCap’s mission is to acquire and develop well-run small and medium-sized life science companies by providing capital, expertise, experience, and networks within each company’s area of business. Through acquisitions, MedCap contributes to strengthening Unimedic Pharma’s existing product portfolio which support our mission to contribute to a better health.

Contact Us, Unimedic Pharma

Interested in partnerships?

Please contact Unimedic Pharma and our Business Development department if you are interested in discussing partnerships, acquisitions, or other collaborations.